top of page

CorQuest MedTech

News

Some key news, events, achievements, milestones.

Day 3 Trck 2 edited 07-0004.jpg

CorQuest MedTech attending LSI Europe 2024

So much value from so many constructive connections. Thanks a lot to MedTech CEOs, to service providers, to investors for their feedback on MithraX! Let's keep moving together.

September 2024

MithraX 90 days follow-up

The CorQuest MedTech team is thrilled to confirm a 90 days follow-up of their MithraX grid and anchors, in an in-vivo ovine implantation!

September 2024

CorQuest 23_29 Ovine 21621_xray_D60_2.jpg
Image by Markus Winkler
Image by Markus Winkler

A new successful fund raising!

In a very challenging period, CorQuest MedTech is extremely happy and excited to confirm an additional successful fund raising. Existing shareholders and new investors have confirmed their belief in the potential of the company and specifically in our MithraX project.

March 2024

CorQuest MedTech and WSL

Formalization of a new partnership. CorQuest MedTech will benefit from the expertise and experience of the WSL - Incubator for tech startups.

November 2023

WSL_CorQuest.jpg
Image by Jonas Vandermeiren

Public funding from the Walloon region

Extremely grateful for the confirmed public funding from the Walloon region. A new financial commitment to help us developing MithraX, our new transcatheter mitral repair solution. Many thanks to the team in Namur for their support and very constructive collaboration.

November 2022

MithraX first test

First tests in vitro of our MithraX device, a disruptive mitral repair technology. Months of design iterations, prototyping and finally an exciting and very constructive day in Leuven, with permanent support of the CorQuest team and our Cisteo Medical partners.

October 2022

team.jpg
Image by Towfiqu barbhuiya

3F fund raising

CorQuest MedTech proudly secured its first fund raising. Thanks a lot to our new partners who believe in our project and in our team. We are now alive and actively launching our first development project, MithraX.

December 2021

bottom of page